Your browser doesn't support javascript.
loading
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.
Galipeau, Jacques; Krampera, Mauro; Barrett, John; Dazzi, Francesco; Deans, Robert J; DeBruijn, Joost; Dominici, Massimo; Fibbe, Willem E; Gee, Adrian P; Gimble, Jeffery M; Hematti, Peiman; Koh, Mickey B C; LeBlanc, Katarina; Martin, Ivan; McNiece, Ian K; Mendicino, Michael; Oh, Steve; Ortiz, Luis; Phinney, Donald G; Planat, Valerie; Shi, Yufang; Stroncek, David F; Viswanathan, Sowmya; Weiss, Daniel J; Sensebe, Luc.
Affiliation
  • Galipeau J; Department of Hematology and Medical Oncology, Winship Cancer Institute, and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: jgalipe@emory.edu.
  • Krampera M; Section of Hematology, Stem Cell Research Laboratory and Cell Factory, Department of Medicine, University of Verona, Verona, Italy.
  • Barrett J; Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dazzi F; Regenerative and Heamatological Medicine, King's College London, London, UK.
  • Deans RJ; Regenerative Medicine, Athersys Inc., Cleveland, OH, USA.
  • DeBruijn J; School of Engineering and Materials Science, Queen Mary University of London, London, UK.
  • Dominici M; Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Fibbe WE; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Centre, Leiden, Netherlands.
  • Gee AP; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, TX, USA.
  • Gimble JM; Center for Stem Cell Research and Regenerative Medicine, Department of Medicine, and Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
  • Hematti P; Department of Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, and University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
  • Koh MB; Department of Haematology, St George's Hospital and Medical School, London, UK; Blood Services Group, Health Sciences Authority, Singapore.
  • LeBlanc K; Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Martin I; Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • McNiece IK; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Mendicino M; Mesoblast Inc., New York, NY, USA.
  • Oh S; Stem Cell Group, Bioprocessing Technology Institute, Agency for Science Technology and Research (A*STAR), Singapore.
  • Ortiz L; Division of Occupational and Environmental Health Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  • Phinney DG; Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA.
  • Planat V; IFR150 STROMALab UMR 5273 UPS-CNRS-EFS-INSERM U1031, Toulouse, France.
  • Shi Y; Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China; The First Affiliated Hospital, Soochow University Institutes for Translational Medicine, Suzhou, China.
  • Stroncek DF; Cell Processing Section, Department of Transfusion Medicine Clinical Center, NIH, Bethesda, MD, USA.
  • Viswanathan S; Cell Therapy Program, University Health Network, Toronto, Canada.
  • Weiss DJ; Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA.
  • Sensebe L; UMR5273 STROMALab CNRS/EFS/UPS-INSERM U1031, Toulouse, France.
Cytotherapy ; 18(2): 151-9, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26724220
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Assay / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Assay / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2016 Type: Article